From 2D to 1D Electronic Dimensionality in Halide Perovskites with Stepped and Flat Layers Using Propylammonium as a Spacer by Justin M. Hoffman (6890504)

“…The RP structures show a blue-shift in bandgap for decreasing <i>n</i> (1.90 eV for <i>n</i> = 4 and 2.03 eV for <i>n</i> = 3), while the SL structures have an even greater blue-shift (2.53 eV for <i>m</i> = 4, 2.74 eV for <i>m</i> = 3, and 2.93 eV for <i>m</i> = 2). …”

From 2D to 1D Electronic Dimensionality in Halide Perovskites with Stepped and Flat Layers Using Propylammonium as a Spacer by Justin M. Hoffman (6890504)

“…The RP structures show a blue-shift in bandgap for decreasing <i>n</i> (1.90 eV for <i>n</i> = 4 and 2.03 eV for <i>n</i> = 3), while the SL structures have an even greater blue-shift (2.53 eV for <i>m</i> = 4, 2.74 eV for <i>m</i> = 3, and 2.93 eV for <i>m</i> = 2). …”

From 2D to 1D Electronic Dimensionality in Halide Perovskites with Stepped and Flat Layers Using Propylammonium as a Spacer by Justin M. Hoffman (6890504)

“…The RP structures show a blue-shift in bandgap for decreasing <i>n</i> (1.90 eV for <i>n</i> = 4 and 2.03 eV for <i>n</i> = 3), while the SL structures have an even greater blue-shift (2.53 eV for <i>m</i> = 4, 2.74 eV for <i>m</i> = 3, and 2.93 eV for <i>m</i> = 2). …”

From 2D to 1D Electronic Dimensionality in Halide Perovskites with Stepped and Flat Layers Using Propylammonium as a Spacer by Justin M. Hoffman (6890504)

“…The RP structures show a blue-shift in bandgap for decreasing <i>n</i> (1.90 eV for <i>n</i> = 4 and 2.03 eV for <i>n</i> = 3), while the SL structures have an even greater blue-shift (2.53 eV for <i>m</i> = 4, 2.74 eV for <i>m</i> = 3, and 2.93 eV for <i>m</i> = 2). …”

V3Nter decreases colony formation and induces tumor cell death in HCT116 and HepG2 cells. by Delphine Quélard (43727)

Decreasing RhoB expression increases Ad5wt-mediated transgene expression. by Dragomira Majhen (462312)

AQP2 and p-AQP2 abundance. by Sophie Constantin Lütken (689916)

Subjects:

RGDfV increases ceramides and decreases sphingomyelins, and these changes are abrogated following ASM. knockdown. by Xiuhai Ren (312555)

Loss of Trib2 decreases disease latency of Notch-driven T-ALL. by Sarah J. Stein (3168600)

“…Mice with a body condition score of ≤2 and decreased mobility were euthanized (n = 8 Trib2^+/+ and n = 12 Trib2^-/- recipients. …”

LAMP1 decreased within MoDCs infected with <i>P. gingivalis</i> expressing Mfa1. by Ahmed R. El-Awady (697683)

<b>Dihydroxyacetone decreases the dATP pool, inducing replication stress and genomic instability in BEAS-2B cells</b> by Saddam Hussain (22282372)

“…DHA exposure reduced ribonucleotide reductase (RRM1/2) expression and specifically depleted dATP pools after 48 h. …”

PrP2 decrease expression results in abnormal PLL development. by Sylvaine Huc-Brandt (667335)

“…Western blot analysis of PrP2 expression using SAF84 antibody shows a decrease of the PrP2 protein after morpholino injections (n = 3 independent experiments).…”

ΔCCR5 transplant decreases tissue viral reservoirs in stably suppressed animals. by Christopher W. Peterson (242655)

CCN3 protein decreases β-cell proliferation. by Renée Paradis (326111)

Decreased capacity to infect is not correlated with a loss of metacyclic promastigotes. by Diana Moreira (186681)

Adaptation decreases the strength of neural responses in A1 neurons. by Mohsen Parto Dezfouli (696276)

Aspirin-Triggered Resolvin D1 does not rescue barrier function in IL-1β-treated A549 cells. by Ruan Cox Jr. (789575)

Translation of Rot and Protein A is decreased in the absence of ClpX. by Lotte Jelsbak (168171)

Dose and time dependent decrease in the viability of cancer cells upon treatment with vitamin D3. by Vidya G. Bettada (22208808)

“…<p>a. Liver cancer cell line Hep G2 was exposed to increasing concentrations of vitamin D3 and its impact on reducing the viability was determined using SRB assay at 24h, 48h and 72h. …”

Decrease in extracellular Zn²⁺ in the hippocampus by zinc chelators. by Atsushi Takeda (18203)

“…<p>Hippocampal slices were prepared 2 h after i.p. injection of vehicle (A, n = 7) or CQ (30 mg/kg, B, n = 5) into NER, and 3 h after i.p. injection of vehicle (C, n = 7) or TPEN (1 mg/kg, D, n = 8) into NER. …”